No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on Esperion Therapeutics, Maintains $16 Price Target
Express News | Esperion Therapeutics Inc : BofA Global Research Cuts Price Objective to $1.85 From $2
Press Release: Esperion to Report First Quarter 2025 Financial Results on May 6
Esperion Therapeutics Inc (ESPR) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
Express News | Esperion Therapeutics Inc Files for Mixed Shelf of up to $400 Mln- SEC Filing
Esperion Therapeutics Is Maintained at Neutral by Goldman Sachs